Psilocybin and New Drugs

The “Right to Try” Psilocybin and New Drug Therapies

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in

Here Comes the First Approved MDMA (Ecstasy) Drug

Here Comes the First Approved MDMA (Ecstasy) Drug

Last week, the Multidisciplinary Association for Psychedelics Studies (MAPS) made a very big announcement: it had raised $30 million to complete its promising study of MDMA (ecstasy; molly) for treating post-traumatic stress disorder (PTSD). The Food and Drug Administration (FDA) already has granted MAPS “breakthrough therapy” approval based on earlier trials. With its recent cash

Schedule I Controlled Substance

How to Study Schedule I Controlled Substances

Q:  I want to study schedule I controlled substances. I want to study marijuana (cannabis), peyote, MDMA, psilocybin, LSD, ayahuasca/DMT and ibogaine, to start. A:  All of that is possible, but you should choose just one. Q:  OK, I want to study cannabis. A:  That’s actually one of the hardest. Please choose a better one.

Cannabis and Psychedelics

The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)

There is a bona fide movement underway with psilocybin. Decriminalization occurred last year in Denver, Oakland and Santa Cruz, and that was just a start: nearly 100 other cities are looking at decriminalizing psychedelics. At the state level, ballot measures are out for signature in California and Oregon. Federally, legislation has been proposed to allow

Psilocybin

This Psilocybin Patent Could Be a Really Big Deal

Last week, COMPASS Pathways announced its acquisition of US Patent No 10,591,175. What does that patent cover? Psilocybin! More specifically, COMPASS has locked down “methods of treating drug-resistant depression with a psilocybin formulation.” The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post

psychedelics law blog

Denver Decriminalizes Psilocybin

On Wednesday, May 8, 2019, Denver, Colorado announced a pass result for Initiated Ordinance 301, becoming the first U.S. jurisdiction to decriminalize psilocybin-containing mushrooms. The ballot title reads as follows: Shall the voters of the City and County of Denver adopt an ordinance to the Denver Revised Municipal Code that would make the personal use

FDA Approves Drug Trial for Psilocybin (Magic Mushrooms)

FDA Approves Drug Trial for Psilocybin (Magic Mushrooms)

Let’s talk about psilocybin today. Psilocybin is the naturally occurring, psychedelic ingredient found in around 200 species of mushrooms. Like cannabis, it is believed that psilocybin use by humans predates recorded history by at least a few thousand years. Also like cannabis, psilocybin has always been thought to have medical applications; and it has demonstrated